David Lee Johnson is Chief Operating Officer of Vera Therapeutics, Inc.. Currently has a direct ownership of 26,900 shares of VERA, which is worth approximately $747,820. The most recent transaction as insider was on Feb 18, 2025, when has been sold 26,900 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.9K
n/a 3M change
n/a 12M change
Total Value Held $747,820

DAVID LEE JOHNSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2025
BUY
Grant, award, or other acquisition
-
26,900 Added 50.0%
26,900 Class A Common Stock

Also insider at

GBT
Global Blood Therapeutics, Inc. Healthcare
CRBU
Caribou Biosciences, Inc. Healthcare
DLJ

David Lee Johnson

Chief Operating Officer
South San Francisco, CA

Track Institutional and Insider Activities on VERA

Follow Vera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERA shares.

Notify only if

Insider Trading

Get notified when an Vera Therapeutics, Inc. insider buys or sells VERA shares.

Notify only if

News

Receive news related to Vera Therapeutics, Inc.

Track Activities on VERA